col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


20 Results       Page 1

 [1] 
Springer-Verlag: Neurology and Therapy
  original article Date Title Authors   All Authors
1 [GO] 2026―Apr―02 Transcutaneous Auricular Vagal Nerve Stimulation Against Fatigue Syndrome in Patients with Long COVID: Results of the Randomized, Placebo-Controlled Clinical Pilot Trial COVIVA Mortimer Gierthmuehlen, Kirsten Schmieder, Niklas Thon, Petra Christine Gierthmuehlen
2 [GO] 2024―Oct―23 COVID-19 Vaccination Response in Patients with Multiple Sclerosis Treated with Ofatumumab in the United States: A Medical Record Review Rahul H. Dave, Heidi Crayton, Augusto Miravalle, Ming-Hui Tai, Kerri Wyse, Katherine Houghton, et al. (+2)
3 [GO] 2023―Dec―14 Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study Jorge Millán-Pascual, Gabriel Valero-López, Francisca Iniesta-Martinez, Maria Fuensanta Hellin-Gil, Judith Jimenez-Veiga, Isabel Alejandra López-Tovar, et al. (+2)
4 [GO] 2023―Jul―08 Cladribine Tablets Mode of Action, Learning from the Pandemic: A Narrative Review Federico Carlini, Valeria Lusi, Caterina Rizzi, Francesco Assogna, Alice Laroni
5 [GO] 2023―Jun―22 Effects of the COVID-19 Pandemic on SMA Screening and Care: Physician and Community Insights Mary Curry, Ilse Peterson, Lisa Belter, Fatou Sarr, Sarah Whitmire, Mary Schroth, Jill Jarecki
6 [GO] 2023―Feb―23 Correction to: Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Onset Following Acute COVID-19 Infection, a Case Series Mirla Avila, Yuanyuan Tan, Roberto Hernandez, Hafsa Zuberi, Victor M. Rivera
7 [GO] 2023―Feb―16 COVID-19 Vaccine Response in People with Multiple Sclerosis Treated with Dimethyl Fumarate, Diroximel Fumarate, Natalizumab, Ocrelizumab, or Interferon Beta Therapy Aliya Jaber, Meera Patel, Andrew Sylvester, Mary Yarussi, J. Tamar Kalina, Jason P. Mendoza, et al. (+2)
8 [GO] 2022―Dec―12 Letter to the Editor Regarding Fleischer et al. Neurological Study Does Not Provide Any Evidence that Long COVID is Psychosomatic Mark Vink, Tilman Grande, Matthias Kohl
9 [GO] 2022―Dec―12 Response Letter to Vink et al. ‘Neurological Study Does Not Provide Any Evidence that Long COVID is Psychosomatic’ Mark Stettner, Michael Fleischer, Eva-Maria Skoda, Martin Teufel, Christoph Kleinschnitz
10 [GO] 2022―Nov―18 Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Onset Following Acute COVID-19 Infection, a Case Series Mirla Avila, YuanYan Tan, Roberto Hernandez, Hafsa Zuberi, Victor M. Rivera
11 [GO] 2022―May―12 COVID-19-Related Burden and Risk Perception in Individuals with Chronic Inflammatory Demyelinating Polyneuropathy and Multifocal Motor Neuropathy: A Cross-Sectional Study Venja Musche, Alexander Bäuerle, Lisa Jahre, Adam Schweda, Hannah Dinse, Sheila Moradian, et al. (+8)
12 [GO] 2022―May―03 Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab Anne H. Cross, Silvia Delgado, Mario Habek, Maria Davydovskaya, Brian J. Ward, Bruce A. C. Cree, et al. (+10)
13 [GO] 2022―Mar―13 COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab Anne H. Cross, Silvia Delgado, Mario Habek, Maria Davydovskaya, Brian J. Ward, Bruce A. C. Cree, et al. (+10)
14 [GO] 2022―Jan―23 Podcast on B Cell-Targeting Therapies and Other Multiple Sclerosis Concerns During COVID-19 Robert K. Shin, Pavle Repovic, Joseph R. Berger
15 [GO] 2021―Oct―29 Simultaneous Occurrence of Cerebral Venous Sinus Thrombosis and Immune Thrombocytopenic Purpura in a Patient with a History of COVID-19 Infection Leyla Bahadorizadeh, Maziar Emamikhah, Arash Pour Mohammad, Milad Gholizadeh Mesgarha
16 [GO] 2021―Oct―10 Multiple Sclerosis, COVID-19 and Vaccines: Making the Point Simona Toscano, Clara G. Chisari, Francesco Patti
17 [GO] 2021―Aug―04 Expert Perspectives on COVID-19 Vaccination for People Living with Multiple Sclerosis Robert K. Shin, Kottil W. Rammohan, Mitzi J. Williams
18 [GO] 2021―Jun―17 Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19 Jihad Inshasi, Raed Alroughani, Abdullah Al-Asmi, Jaber Alkhaboury, Abdullah Alsalti, Amir Boshra, et al. (+5)
19 [GO] 2021―Apr―15 The COVID-19 Pandemic Experience in Multiple Sclerosis: The Good, the Bad and the Neutral Hannah Morris-Bankole, Aileen K. Ho
20 [GO] 2020―Nov―23 SARS-CoV-2 Infection: Symptoms of the Nervous System and Implications for Therapy in Neurological Disorders Jacek Losy
 [1] 

20 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec